| 2024-11-20 | +0.97 % |
|
| 2024-11-19 | -0.75 % |
|
| 2024-11-04 | +0.84 % |
|
| 2024-10-31 | -1.55 % |
|
| 2024-10-30 | -1.42 % |
|
| 2024-10-28 | +2.42 % |
|
| 2024-10-23 | +0.37 % |
|
| 2024-10-22 | -4.67 % |
|
| 2024-10-18 | -0.01 % |
|
| 2024-10-16 | +0.64 % |
|
| 2024-10-14 | +0.09 % |
|
| 2024-10-10 | +1.99 % |
|
| 2024-10-09 | +0.47 % |
|
| 2024-10-07 | -0.8 % |
|
| 2024-10-01 | -1.47 % |
|
| 2024-09-27 | +0.03 % |
|
| 2024-09-25 | -3.85 % |
|
| 2024-09-17 | +1.22 % |
|
| 2024-09-06 | -1.69 % |
|
| 2024-08-08 | +0.99 % |
|
| 2024-08-07 | -12.6 % |
|
| 2024-06-28 | -0.37 % |
|
| 2024-06-27 | +0.31 % |
|
| 2024-06-25 | -1.65 % |
|
| 2024-06-11 | -1.9 % |
|
| 2024-06-10 | -0.13 % |
|
| 2024-06-07 | -3.08 % |
- Summary: Research analysts at Mizuho initiated coverage on Charles River Laboratories International (CRL) with a "neutral" rating and a $235.00 price target, with other firms providing positive ratings on the stock as well; however, CRL stock went down 3.08%, possibly influenced by general market trends or investor sentiment.
Reason for Stock Decline: The decrease in Charles River Laboratories International (CRL) stock price by 3.08% could be attributed to general market movements, changes in investor sentiment, profit-taking by some investors, or perhaps due to factors affecting the broader healthcare or biotech industry.
- The article discusses Charles River Laboratories International Inc. (CRL) stock, which experienced a 3.08% decrease, with market information indicating significant changes in investor positions, including First Trust Advisors LP reducing its stake in the company. The stock decline may be attributed to these changes in ownership, combined with analyst ratings, recent insider transactions, and the company's latest earnings report exceeding expected earnings per share.
- Summary: The article discusses how various brokerages have issued ratings and price targets for Charles River Laboratories International (CRL) stock, with Goldman Sachs giving it a buy rating and a target price of $290. However, despite positive analyst ratings, the stock was down by 3.08% last night.
Reason for Stock Movement: The stock of Charles River Laboratories International (CRL) could have gone down due to various factors such as broader market trends, changes in investor sentiment, macroeconomic factors, or profit-taking by investors following the recent rise in the stock price. It is important to consider multiple factors influencing the stock market to understand the specific reason for the decrease in CRL stock.
|
| 2024-06-06 | +2.54 % |
|
| 2024-06-04 | +1.11 % |
|
